Back to catalog
Weight & Metabolism
Retatrutide
Choose an option
Select the amount per vial, then choose a package size.
Amount per vial
Package size
Your estimate includes a flat $65 shipping charge and an 8% transaction fee on the product subtotal. No payment is collected here.
Overview
Triple agonist (GLP-1, GIP, glucagon) for advanced metabolic research. Potent weight loss and glucose control compound under clinical investigation.
- Selected variation
- Retatrutide 100mg
- Amount per vial
- 100mg
- Intended use
- Laboratory research only
- Route of administration
- Subcutaneous injection
Research information
Retatrutide is a novel triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors, studied for metabolic regulation and weight management.
For laboratory research only. Not for human or animal consumption. Catalog information is not medical advice or a claim of therapeutic benefit.